Cristal Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.67 M
- Company Age 29 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.31 Cr
- Revenue Growth 12.83%
- Profit Growth 7.99%
- Ebitda -7.27%
- Net Worth 2.44%
- Total Assets -31.81%
About Cristal Pharma
Cristal Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 1996 and has a history of 29 years. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.67 M.
The company currently has active open charges totaling ₹1.31 Cr.
Sharad Navathe, Alka Navathe, and Rasika Navathe serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24234PN1996PTC096465
- Company No.
096465
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 1996
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Cristal Pharma Private Limited offer?
Cristal Pharma Private Limited offers a wide range of products and services, including Antiseptic Gel, Lotion & Cream, Antiseptic Liquid, Ultrasound Accessories, ECG Gel, API (Active Pharmaceutical Ingredients), Disinfectant Chemicals, Diagnostic Imaging Accessories, API Intermediate.
Who are the key members and board of directors at Cristal Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Navathe  | Additional Director | 26-Jul-2023 | Current |
| Alka Navathe | Director | 19-Jan-1996 | Current |
| Rasika Navathe | Additional Director | 01-May-2021 | Current |
Financial Performance of Cristal Pharma.
Cristal Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 12.83% increase. The company also saw a slight improvement in profitability, with a 7.99% increase in profit. The company's net worth moved up by a moderate rise of 2.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cristal Pharma?
In 2021, Cristal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹13.08 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Apr 2004 | State Bank Of India | ₹0.45 M | Open |
| 13 Sep 2000 | State Bank Of India | ₹1.05 Cr | Open |
| 13 Sep 2000 | State Bank Of India | ₹0.93 M | Open |
| 24 Dec 1997 | State Bank Of India | ₹0.70 M | Open |
| 24 Dec 1997 | State Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Cristal Pharma?
Cristal Pharma has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cristal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cristal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
